Ben Andrews1, Levy Muchemwa, Paul Kelly, Shabir Lakhi, Douglas C Heimburger, Gordon R Bernard. 1. 1Institute for Global Health, Vanderbilt University, Nashville, TN. 2Division of General Internal Medicine and Public Health, Department of Internal Medicine, Vanderbilt University, Nashville, TN. 3Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia. 4Barts and the London School of Medicine, London, United Kingdom. 5Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia. 6Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University, Nashville, TN.
Abstract
OBJECTIVE: To assess the efficacy of a simple, goal-directed sepsis treatment protocol for reducing mortality in patients with severe sepsis in Zambia. DESIGN: Single-center nonblinded randomized controlled trial. SETTING:Emergency department, ICU, and medical wards of the national referral hospital in Lusaka, Zambia. PATIENTS: One hundred twelve patients enrolled within 24 hours of admission with severe sepsis, defined as systemic inflammatory response syndrome with suspected infection and organ dysfunction INTERVENTIONS: : Simplified Severe Sepsis Protocol consisting of up to 4 L of IV fluids within 6 hours, guided by jugular venous pressure assessment, and dopamine and/or blood transfusion in selected patients. Control group was managed as usual care. Blood cultures were collected and early antibiotics administered for both arms. MEASUREMENTS AND MAIN RESULTS: Primary outcome was in-hospital all-cause mortality. One hundred nine patients were included in the final analysis and 88 patients (80.7%) were HIV positive. Pulmonary infections were the most common source of sepsis. In-hospital mortality rate was 64.2% in the intervention group and 60.7% in the control group (relative risk, 1.05; 95% CI, 0.79-1.41). Mycobacterium tuberculosis complex was isolated from 31 of 82 HIV-positive patients (37.8%) with available mycobacterial blood culture results. Patients in Simplified Severe Sepsis Protocol received significantly more IV fluids in the first 6 hours (2.7 L vs 1.7 L, p = 0.002). The study was stopped early because of high mortality rate among patients with hypoxemic respiratory failure in the intervention arm (8/8, 100%) compared with the control arm (7/10, 70%; relative risk, 1.43; 95% CI, 0.95-2.14). CONCLUSION: Factors other than tissue hypoperfusion probably account for much of the end-organ dysfunction in African patients with severe sepsis. Studies of fluid-based interventions should utilize inclusion criteria to accurately capture patients with hypovolemia and tissue hypoperfusion who are most likely to benefit from fluids. Exclusion of patients with severe respiratory distress should be considered when ventilatory support is not readily available.
RCT Entities:
OBJECTIVE: To assess the efficacy of a simple, goal-directed sepsis treatment protocol for reducing mortality in patients with severe sepsis in Zambia. DESIGN: Single-center nonblinded randomized controlled trial. SETTING: Emergency department, ICU, and medical wards of the national referral hospital in Lusaka, Zambia. PATIENTS: One hundred twelve patients enrolled within 24 hours of admission with severe sepsis, defined as systemic inflammatory response syndrome with suspected infection and organ dysfunction INTERVENTIONS: : Simplified Severe Sepsis Protocol consisting of up to 4 L of IV fluids within 6 hours, guided by jugular venous pressure assessment, and dopamine and/or blood transfusion in selected patients. Control group was managed as usual care. Blood cultures were collected and early antibiotics administered for both arms. MEASUREMENTS AND MAIN RESULTS: Primary outcome was in-hospital all-cause mortality. One hundred nine patients were included in the final analysis and 88 patients (80.7%) were HIV positive. Pulmonary infections were the most common source of sepsis. In-hospital mortality rate was 64.2% in the intervention group and 60.7% in the control group (relative risk, 1.05; 95% CI, 0.79-1.41). Mycobacterium tuberculosis complex was isolated from 31 of 82 HIV-positivepatients (37.8%) with available mycobacterial blood culture results. Patients in Simplified Severe Sepsis Protocol received significantly more IV fluids in the first 6 hours (2.7 L vs 1.7 L, p = 0.002). The study was stopped early because of high mortality rate among patients with hypoxemic respiratory failure in the intervention arm (8/8, 100%) compared with the control arm (7/10, 70%; relative risk, 1.43; 95% CI, 0.95-2.14). CONCLUSION: Factors other than tissue hypoperfusion probably account for much of the end-organ dysfunction in African patients with severe sepsis. Studies of fluid-based interventions should utilize inclusion criteria to accurately capture patients with hypovolemia and tissue hypoperfusion who are most likely to benefit from fluids. Exclusion of patients with severe respiratory distress should be considered when ventilatory support is not readily available.
Authors: Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: L K Archibald; L C McDonald; O Nwanyanwu; P Kazembe; H Dobbie; J Tokars; L B Reller; W R Jarvis Journal: J Infect Dis Date: 2000-04-13 Impact factor: 5.226
Authors: Shravan Kethireddy; R Bruce Light; Yazdan Mirzanejad; Dennis Maki; Yaseen Arabi; Stephen Lapinsky; David Simon; Aseem Kumar; Joseph E Parrillo; Anand Kumar Journal: Chest Date: 2013-08 Impact factor: 9.410
Authors: F N Ssali; M R Kamya; F Wabwire-Mangen; S Kasasa; M Joloba; D Williams; R D Mugerwa; J J Ellner; J L Johnson Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-12-15
Authors: Shevin T Jacob; Patrick Banura; Jared M Baeten; Christopher C Moore; David Meya; Lydia Nakiyingi; Rebecca Burke; Cheryl Lynn Horton; Boaz Iga; Anna Wald; Steven J Reynolds; Harriet Mayanja-Kizza; W Michael Scheld Journal: Crit Care Med Date: 2012-07 Impact factor: 7.598
Authors: Inipavudu Baelani; Stefan Jochberger; Thomas Laimer; Dave Otieno; Jane Kabutu; Iain Wilson; Tim Baker; Martin W Dünser Journal: Crit Care Date: 2011-01-10 Impact factor: 9.097
Authors: Shevin T Jacob; Christopher C Moore; Patrick Banura; Relana Pinkerton; David Meya; Pius Opendi; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; W Michael Scheld Journal: PLoS One Date: 2009-11-11 Impact factor: 3.240
Authors: Olivier Urayeneza; Pierre Mujyarugamba; Zacharie Rukemba; Vincent Nyiringabo; Polyphile Ntihinyurwa; John I Baelani; Arthur Kwizera; Danstan Bagenda; Mervyn Mer; Ndidiamaka Musa; Julia T Hoffman; Ashok Mudgapalli; Austin M Porter; Niranjan Kissoon; Hanno Ulmer; Lori A Harmon; Joseph C Farmer; Martin W Dünser; Andrew J Patterson Journal: Intensive Care Med Date: 2018-06-28 Impact factor: 17.440
Authors: Maurizio Cecconi; Glenn Hernandez; Martin Dunser; Massimo Antonelli; Tim Baker; Jan Bakker; Jacques Duranteau; Sharon Einav; A B Johan Groeneveld; Tim Harris; Sameer Jog; Flavia R Machado; Mervyn Mer; M Ignacio Monge García; Sheila Nainan Myatra; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Daniel De Backer Journal: Intensive Care Med Date: 2018-11-19 Impact factor: 17.440
Authors: Christopher W Seymour; Jason N Kennedy; Shu Wang; Chung-Chou H Chang; Corrine F Elliott; Zhongying Xu; Scott Berry; Gilles Clermont; Gregory Cooper; Hernando Gomez; David T Huang; John A Kellum; Qi Mi; Steven M Opal; Victor Talisa; Tom van der Poll; Shyam Visweswaran; Yoram Vodovotz; Jeremy C Weiss; Donald M Yealy; Sachin Yende; Derek C Angus Journal: JAMA Date: 2019-05-28 Impact factor: 56.272
Authors: Daniel De Backer; Jan Bakker; Maurizio Cecconi; Ludhmila Hajjar; Da Wei Liu; Suzanna Lobo; Xavier Monnet; Andrea Morelli; Sheila Neinan Myatra; Azriel Perel; Michael R Pinsky; Bernd Saugel; Jean-Louis Teboul; Antoine Vieillard-Baron; Jean-Louis Vincent Journal: Intensive Care Med Date: 2018-05-03 Impact factor: 17.440
Authors: Wesley H Self; Matthew W Semler; Rinaldo Bellomo; Samuel M Brown; Bennett P deBoisblanc; Matthew C Exline; Adit A Ginde; Colin K Grissom; David R Janz; Alan E Jones; Kathleen D Liu; Stephen P J Macdonald; Chadwick D Miller; Pauline K Park; Lora A Reineck; Todd W Rice; Jay S Steingrub; Daniel Talmor; Donald M Yealy; Ivor S Douglas; Nathan I Shapiro Journal: Ann Emerg Med Date: 2018-05-10 Impact factor: 5.721
Authors: Jennifer Rickard; Christian Ngarambe; Leonard Ndayizeye; Blair Smart; Robert Riviello; Jean Paul Majyambere Journal: World J Surg Date: 2018-10 Impact factor: 3.352
Authors: Matthew W Semler; Arthur P Wheeler; B Taylor Thompson; Gordon R Bernard; Herbert P Wiedemann; Todd W Rice Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598